2024年4月24日 · In 2022, Brazil had 2578 deaths from hepatitis B and 2977 from hepatitis C. Because hepatitis is a silent disease, diagnosis often comes late, when the disease is already …

Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC) worldwide. HBV infection is prevalent in Asia, Africa, Southern Europe and …

Hepatitis B protection. The two main issues related to HBV vaccination are persistence over time of antibodies and whether the waning or disappearance of antibodies permits a response to …

For patients with chronic viral hepatitis, clinicians instinctively rely on liver enzyme measurements to estimate disease activity and assess need for liver biopsy or antiviral treatment. Although ...

2024年9月6日 · Hepatitis B : Review in-depth clinical information, latest medical news, and guidelines on hepatitis B infection. Read the latest on prevention of hepatitis B virus with the …

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Those with chronic hepatitis B (CHB) have up to a 15 to 40% risk of developing cirrhosis and hepatocellular carcinoma in their lifetime. In Africa and Asia, 8 to 10% of the adult population is ...

Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel. [1 ...

2024年8月30日 · US FDA Declines Expanded Use Of Dynavax's Hepatitis B Vaccine on Insufficient Data Maternal Hepatitis C Virus Infection Linked to Increased NICU Admissions …

Hepatitis B virus (HBV) is a major global health concern with >350 million people chronically infected. [] The strategy for the control of HBV infection, as outlined by the World Health ...